Biogen's chart data is dated 2026-10-09. Recorded technical signals: Near 52-week high, Golden cross, MA aligned, VCP. There are 14 published signal records.
Biogen last closed at $225.71 (+3.33%) on 2026-10-09. Signals today: Near 52-week high, Golden cross, MA aligned, VCP. Listed on Nasdaq. Trailing 12 months PER is 38.9×. Its overall grade ranks 393 of 738 stocks in Healthcare.
About this company
Biogen last closed at $225.71 (+3.33%) on 2026-10-09. Signals today: Near 52-week high, Golden cross, MA aligned, VCP. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 393/738
Valuation grade F
Related stocks
- Eli LillyCompetitor
알츠하이머 치료제와 중추신경계 질환 영역에서 직접 경쟁
- EisaiCompetitor
레켐비(Leqembi)로 알츠하이머 치료 시장에서 Biogen과 경쟁
- RocheCompetitor
다발성경화증·신경질환 및 알츠하이머 치료제 개발에서 경쟁
ETFs holding this stock
Invesco Dynamic BioTech & Genome ETF · iShares Neuroscience and Healthcare ETF · The Free Markets ETF
Details →About Biogen
- What technical signals does Biogen (BIIB) have?
- Biogen current technical signals: golden cross (5_20, 0d ago), MA alignment (score 0.42).
- Is Biogen a cup-and-handle pattern?
- No. Biogen has no valid Cup signal right now.
- What published figures are available for Biogen?
- Market cap: $33.11B. Trailing 12 months PER: 38.9×. Latest quarter PBR: 1.72×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Biogen, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.